Ashton Thomas Private Wealth LLC Increases Stock Holdings in Amdocs Limited $DOX

Ashton Thomas Private Wealth LLC lifted its stake in shares of Amdocs Limited (NASDAQ:DOX) by 226.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 76,084 shares of the technology company’s stock after purchasing an additional 52,810 shares during the quarter. Ashton Thomas Private Wealth LLC owned about 0.07% of Amdocs worth $6,283,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of DOX. Harbor Capital Advisors Inc. acquired a new stake in shares of Amdocs in the 3rd quarter worth $26,000. Root Financial Partners LLC purchased a new position in Amdocs during the third quarter worth about $26,000. Rossby Financial LCC acquired a new stake in Amdocs in the second quarter valued at about $41,000. Atlantic Union Bankshares Corp purchased a new stake in Amdocs in the 3rd quarter valued at approximately $37,000. Finally, Caitong International Asset Management Co. Ltd increased its position in Amdocs by 537.8% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 472 shares of the technology company’s stock worth $43,000 after purchasing an additional 398 shares during the period. 92.02% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Stifel Nicolaus reduced their price target on Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday. Wall Street Zen downgraded Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, January 3rd. Bank of America lowered their price target on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Finally, Barclays set a $92.00 target price on shares of Amdocs in a research report on Wednesday. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Amdocs has a consensus rating of “Moderate Buy” and a consensus target price of $92.33.

Amdocs Stock Performance

NASDAQ:DOX opened at $73.06 on Thursday. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $7.89 billion, a P/E ratio of 14.13, a price-to-earnings-growth ratio of 1.25 and a beta of 0.40. The firm has a 50-day moving average price of $80.31 and a two-hundred day moving average price of $82.57. Amdocs Limited has a twelve month low of $70.32 and a twelve month high of $95.41.

Amdocs (NASDAQ:DOX) last released its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, beating the consensus estimate of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.13%. The business had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.15 billion. During the same period in the prior year, the business earned $1.66 earnings per share. The company’s quarterly revenue was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, research analysts expect that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be issued a $0.569 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.1%. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date of this dividend is Tuesday, March 31st. Amdocs’s payout ratio is presently 40.81%.

Key Stories Impacting Amdocs

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Q1 results beat consensus — Amdocs reported $1.81 EPS on $1.16B revenue, above estimates and up year-over-year, which supports the business outlook and helped lift sentiment initially. Amdocs (DOX) Q1 2026 Earnings Call Transcript
• Positive Sentiment: Large customer win and commercial traction — Amdocs extended a multi-year strategic deal with T‑Mobile (managed services, software, AI work including UScellular integration), reinforcing recurring revenue and services demand. T‑Mobile USA Enters Strategic Multi-Year Agreement with Amdocs
• Positive Sentiment: Product / market expansion — Amdocs launched aOS (agentic OS for telecom) and won a MarketONE deal with VIDAA for OTT bundled experiences, highlighting its push into AI-enabled telecom automation and media monetization. These should support longer-term growth and cross-sell. Amdocs Introduces aOS VIDAA Selects Amdocs MarketONE
• Positive Sentiment: Dividend increase — Board raised the quarterly dividend ~8% to $0.569 (annualized yield ~3.1%), which supports income-oriented investor demand and signals confidence in cash flow.
• Neutral Sentiment: FY26 guidance and Q2 outlook were updated (FY EPS range 7.27–7.55; Q2 EPS 1.73–1.79). On the surface ranges are near or above consensus, but language and trajectory prompted mixed interpretation by the market. Amdocs FY26 Guidance / Press Release
• Neutral Sentiment: Analyst action — Stifel cut its price target from $97 to $88 but maintained a Buy rating, reflecting mixed analyst views (valuation trimmed but still upside). Stifel Lowers PT on Amdocs
• Negative Sentiment: Management transition fuels uncertainty — Long-time CEO Shuky Sheffer will retire March 31; Shimie Hortig will succeed him. Leadership change at the top can increase short-term execution risk and investor uncertainty. Amdocs Appoints Shimie Hortig as CEO Amdocs Announces CEO Succession
• Negative Sentiment: Market reaction — Headlines tying the CEO transition and perceived guidance tightening to a downgrade in confidence prompted a notable share pullback (coverage noted a ~10% drop on related headlines), indicating short-term risk to the stock. Amdocs Is Down After Lowering Guidance and Announcing CEO Transition

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.